852380-82-6

Basic information

• Product Name: [3-(tert-butyl-dimethyl-silanyloxy)-1,5-dihydroxy-4-methylene-cyclohexyl]-[1-(2-trimethylsilanyl-ethoxymethyl)-1H-indol-2-yl]-methanone
• Synonyms: [3-(tert-butyl-dimethyl-silanyloxy)-1,5-dihydroxy-4-methylene-cyclohexyl]-[1-(2-trimethylsilanyl-ethoxymethyl)-1H-indol-2-yl]-methanone
• CAS NO: 852380-82-6
• Molecular Weight: 531.84
• Mol File: 852380-82-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [3-(tert-butyl-dimethyl-silanyloxy)-1,5-dihydroxy-4-methylene-cyclohexyl]-[1-(2-trimethylsilanyl-ethoxymethyl)-1H-indol-2-yl]-methanone(CAS DataBase Reference)
• NIST Chemistry Reference: [3-(tert-butyl-dimethyl-silanyloxy)-1,5-dihydroxy-4-methylene-cyclohexyl]-[1-(2-trimethylsilanyl-ethoxymethyl)-1H-indol-2-yl]-methanone(852380-82-6)
• EPA Substance Registry System: [3-(tert-butyl-dimethyl-silanyloxy)-1,5-dihydroxy-4-methylene-cyclohexyl]-[1-(2-trimethylsilanyl-ethoxymethyl)-1H-indol-2-yl]-methanone(852380-82-6)

Safety Data

• Hazardous Substances Data: 852380-82-6(Hazardous Substances Data)

Upstream product

• 852380-73-5 2-bromo-1-(2-trimethylsilanyl-ethoxymethyl)-1H-indole 
• 852380-46-2 (1R,3R,5R)-3-(tert-Butyl-dimethyl-silanyloxy)-1-hydroxy-4-methylene-6-oxa-bicyclo[3.2.1]octan-7-one 
• 77-95-2 D-(-)-quinic acid 
• 139409-34-0 2-bromo-1H-indole 
• 163217-18-3 (1R,3R,4S,5R)-3-[(tert-butyldimethylsilyl)oxy]-1,4-dihydroxy-6-oxa-bicyclo[3.2.1]octan-7-one 
• 665-27-0 1,5-quinide 
• 766529-94-6 (1R,3R,5R)-3-[(tert-butyldimethylsilyl)oxy]-1-hydroxy-6-oxa-bicyclo[3.2.1]octane-4,7-dione 

Downstream Products

• 852380-84-8 [3-(tert-butyl-dimethyl-silanyloxy)-1,5-dihydroxy-4-methylene-cyclohexyl]-[1-(2-trimethylsilanyl-ethoxymethyl)-1H-indol-2-yl]-methanone 
• 852380-86-0 [5-(tert-butyl-dimethyl-silanyloxy)-1-hydroxy-4-methyl-cyclohex-3-enyl]-[1-(2-trimethylsilanyl-ethoxymethyl)-1H-indol-2-yl]-methanone 
• 852380-83-7 [3,5-bis-(tert-butyl-dimethyl-silanyloxy)-1-hydroxy-4-methylene-cyclohexyl]-[1-(2-trimethylsilanyl-ethoxymethyl)-1H-indol-2-yl]-methanone 

Relevant articles and documents

Development of an enantiodivergent strategy for the total synthesis of (+)- and (-)-dragmacidin f from a single enantiomer of quinic acid

An enantiodivergent strategy for the total chemical synthesis of both (+)- and (-)-dragmacidin F beginning from a single enantiomer of quinic acid has been developed and successfully implemented. Although unique, the synthetic routes to these antipodes share a number of key features, including novel reductive isomerization reactions, Pd(II)-mediated oxidative carbocyclization reactions, halogen-selective Suzuki couplings, and high-yielding late-stage Neber rearrangements.